Enthesis Differences in Rheumatoid Arthritis and Axial Spondyloarthropathy
NCT ID: NCT05942976
Last Updated: 2023-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
106 participants
OBSERVATIONAL
2023-06-16
2023-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis
NCT04946539
Ultrasonographic Evaluation of the Shoulder Joint in Patients With Axial Spondyloarthritis
NCT06727266
Ultrasonographic Evaluation of Asymptomatic Shoulder Joint Pathologies in Rheumatoid Arthritis Patients
NCT06572696
Anti-TNF Therapy and Nerve Conduction Studies in Ankylosing Spondylitis
NCT04943237
Ultrasonography as a Biomarker in Early Rheumatoid Arthritis
NCT00781989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1: axial spondyloarthritis
SpA patients identified according to the Assessment of Spondyloarthritis classification criteria
ULTRASOUND
10 enthesis areas will be evaluated in 20 minutes with ultrasound.
group 2: Rheumatoid arthritis
RA patients identified according to the 2010 American College of Rheumatology/Europan Leage Against Rheumatism classification criteria
ULTRASOUND
10 enthesis areas will be evaluated in 20 minutes with ultrasound.
group:3 Healthy Control
healthy controls with no history of rheumatic diseases
ULTRASOUND
10 enthesis areas will be evaluated in 20 minutes with ultrasound.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ULTRASOUND
10 enthesis areas will be evaluated in 20 minutes with ultrasound.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* axial Spondyloarthrtis patients identified according to the Assessment of Spondyloarthritis classification criteria
* healthy controls with no history of rheumatic diseases.
Exclusion Criteria
* metabolic disease (diabetes mellitus, hypothyroidism),
* malignant neoplasm,
* limitation of range of motion in the extremity,
* those who have received corticosteroid injections in the last 3 months,
* uncontrollable fibromyalgia.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Burak Tayyip Dede
Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Training and Resarch Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16/09/2022; 2011-KAEK-50;288
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.